Global Market Presence Establishment Labs has an extensive footprint with approvals in over 70 countries and operates at two FDA-compliant facilities in Costa Rica, offering considerable opportunity to expand sales through both existing and new distribution channels.

Innovative Product Portfolio The company's flagship Motiva Implants, supported by ongoing FDA clinical trials and positive 5-year US trial results, position it as a leader in advanced breast aesthetic solutions, appealing to high-end clinics seeking cutting-edge technology.

Legal and Patent Strategy Recent patent infringement litigation highlights the company's focus on defending its intellectual property, signaling a need for strategic partnerships with distributors who value proprietary technology and legal robustness.

Financial Growth Potential With revenues between 100 million and 250 million dollars and ongoing global expansion efforts, Establishment Labs offers promising upsell opportunities for suppliers of high-quality manufacturing equipment and design software.

Strategic Innovations The launch of Preservé in Brazil and initiatives like the Young Investor program demonstrate the company's interest in market diversification and consumer engagement, presenting cross-selling prospects for educational and patient awareness solutions.